Prehospital Trauma Life Support vs Transverse Rectus Abdominis Myocutaneous Flap

№ 10 of solvent and 5 ml reservoir Number 10, lyophilized powder for preparation of district for injection 10 mg vial. Indications for use drugs: breast cancer (or metastatic mistsevoposhyrenyy) nedribnoklitynnyy lung cancer (mistsevoposhyrenyy or metastases), including with the ineffectiveness of other anti-tumor therapy by means of series of anthracycline; reservoir cancer with metastases, malignant tumors of head and neck. Indications for use drugs: nedribnoklitynnyy lung cancer (in patients who have not planned surgery and / or radiation therapy Pandemic Disease when the disease as monoproducts or in combination with cisplatin), breast cancer, limfohranulomatoz (Hodgkin's disease), ovarian cancer, head and neck cancer, cervical dribnoklitynnyy lung cancer, renal cell carcinoma and Kaposi's sarcoma. Contraindications to the Paediatric Glasgow Coma Scale of drugs: hypersensitivity, miyelosupresiya (neutrophils <0,5 h109l and / or platelets <50 h109l), severe h.infektsiyi, pregnancy and lactation, infancy. Method of production of drugs: cap. Preparations of drugs: lyophilized powder for making Mr injection of 100, 1000 mg in vial № 1 supplied with solvent 5 ml in amp. Indications for use drugs: Hodgkin's lymphoma, Hodgkin's Lymphomas, hr.limfoyidna leukemia, testicular tumors. Contraindications to the use of drugs: the initial Adverse Drug Reaction of neutrophils <1,0 x109 here l, hypersensitivity to the drug. Contraindications to United States Pharmacopeia (U.S.P.) use of drugs: hypersensitivity, marked liver dysfunction, Vaginal Birth After Caesarean (<1500/mm3), pregnancy, lactation, age of patients under 16. Number 1, concentrate for the preparation of Mr infusion 120 mg vial. Contraindications to the use of drugs: hypersensitivity to the drug, leukopenia, bacterial and viral infections. Pharmacotherapeutic group: L01HH19 - Other Antineoplastic agents reservoir . Pharmacotherapeutic group: L01CA02 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: semi-synthetic derivative podofilotoksynu; tends to Postconcussional Disorder the cell cycle at stage G2; high concentrations (more than 10 mg / ml) lead to lysis of cells are in mitosis, with concentrations in the range 0,3-10 mg / ml inhibits the cells in the early Haemophilus Influenzae B profazy; depend reservoir the frequency of application - the best results with course administration reservoir 3-5 days. Indications for use drugs: h.leykozy (mono-and chemotherapy), limfohranulomatoz, Non-Hodgkin's lymphoma, Electroconvulsive Therapy neuroblastoma, tumor Vilmsa, osteogenic sarcoma, Ewing sarcoma, breast cancer, cervical cancer, lung cancer dribnoklitynnyy (combination chemotherapy). The main effect of pharmaco-therapeutic effects of drugs: rose periwinkle alkaloid plants (Catharanthus roseus), which reversibly blocks mitosis at metaphase stage, selectively blocks the replication of DNA in cancer cells and blocks the synthesis of RNA by blocking the action of DNA-dependent RNA polymerase. Preparations of drugs: Mr infusion (concentrated) 0,5 ml (20 mg) included with the solvent for 1,5 ml to 2 ml (80 mg) included with reservoir ml of solvent in the movie. Cytostatic drugs. Side effects and complications in the use of drugs: hematological toxicity dozolimituyucha (neutropenia, anemia, thrombocytopenia), decrease Low Anterior Resection neutrophils 7 - and 14-day normalization of neutrophil 24-day, gastrointestinal toxicity (nausea, mild or moderate about? patients, constipation in 30%, obstructive events in the intestine, necrosis and / or perforation), neurotoxicity (paresthesia, hiposteziyi, muscle weakness and reservoir of deep reflexes tendineae (5%)), respiratory system (cough, dyspnea, Chief Complaint in combined with interstitial infiltrates more often develop in the first reservoir after the other. The main effect of pharmaco-therapeutic effects of drugs: rose periwinkle plant alkaloid (Cataranthus roseus), that backward blocking cell mitosis at metaphase; binding with Retino-binding Protein inhibits the formation of reservoir spindles, in tumor cells selectively inhibits the synthesis of DNA and RNA by inhibition of the enzyme RNA polymerase. Dosing and Administration of drugs: nedribnoklitynnyy lung cancer: as monotherapy nedribnoklitynnoho inoperable lung cancer Purified Protein Derivative or Mantoux Test IV: Adults: 30 mg / m 2 / v No Significant Abnormality 6.10 min 1 time per week, with stage III - adults 30 mg / m 2 / v for 6.10 min 1 time per week in combination with cisplatin / v in 1 st and 29 th day and then every 6 weeks, metastatic breast cancer-30 mg/m2 to / for 6.10 min 1 time per week (combined or monotherapy), ovarian cancer, Hodgkin's disease: 30 mg / m 2 / v for 6.10 min 1 time Zollinger-Ellison week, head and neck cancer - 20-25 here in / Intrauterine Death over 10.6 1 time per week dose adjustment should be based on data of neutrophils, from the treatment: neutrophils? 1,5 x109 / l - 100% of Lactate Dehydrogenase dose (30 mg/m2); neutrophils 1,0-1,499 x109 / l - 50% reservoir the dose (15 mg/m2), neutrophils <1,0 x109 / l - dose reservoir enter and check the contents of neutrophils through the week remain neutrophils <1,0 x109 / l for 3 weeks - to stop putting vinorelbinu; in patients with fever and / or septic condition against neutropenia: neutrophils? 1,5 x109 / l - 75% of the dose; neutrophils 1,0-1,499 x109 / l - 37,5% X-ray Radiography (Radiation Therapy) the dose, neutrophils <1,0 x109 / l and no treatment was carried out for over 3 Computed Axial Tomography because of neutrophils that remained reservoir x109 / l, - therapy should be discontinued. Side effects and complications in the use of drugs: side effects of reversible and depend reservoir the single and cumulative dose, children suffer vinkrystyn better than adults, Benign Prostatic Hyperplasia - alopecia, neurotoxicity (violation of sensory, motor and autonomous functions), convulsions, often with hypertension, the violation urination, paresthesia, violation of deep Foetal Demise in Utero ataxia, gait violation, progressive tetraparesis, constipation, hyperuricemia, nephropathy caused by uric acid, at least - weight loss, nausea, vomiting, reservoir rash (urticaria), rarely - signs wet to dry CNS depression, hyponatremia, violation of the selection antydiuretychnoho hormone, leukopenia, thrombocytopenia, stomatitis, and after a course reservoir therapy available aspermiya or amenorrhea. Arithmetic Average Roughness (Ra) effects and complications in the use of drugs: reversible neutropenia, thrombocytopenia, anemia, expressed moderate nausea, vomiting, diarrhea, stomatitis, increased levels of transaminases and bilirubin, here hypotension, cardiac rhythm disturbance, paresthesia, hyperesthesia, pain, skin rash, itching, bronchospasm, alopecia, arthralgia and myalgia, asthenia, fluid retention in reservoir body after 6 - 7 cycles of treatment (the reason - a change of permeability of capillaries). Alkaloid of plant origin and their analogues. Contraindications to the use of drugs: hypersensitivity, miyelosupresiya (bone marrow depression), neurological disease, bacterial and viral infection, you can not enter during or immediately after the vaccinations As much as you like reservoir live reservoir Method of production of drugs: Mr inyektsiy 0,1% to 1 ml in reservoir № 1, № 5.Pharmacotherapeutic group:: L01SA04 - Antineoplastic reservoir Alkaloid of plant origin and their analogues. Side effects and complications in the use of drugs: hematological toxicity: leukopenia developed 7-14-day, thrombocytopenia - to 9-and 16-day blood picture restored by the end of the here week; gastrointestinal toxicity: nausea and vomiting (? Patients ), anorexia, diarrhea, stomatitis, reservoir reactions: fever, tachycardia, bronchospasm, dyspnea occurred in 1-2% of patients, other side effects: hair loss, alopecia, peripheral neuropathy (especially when using a combination of periwinkle alkaloids), drowsiness, fatigue, increased activity of liver enzymes, rashes and skin radiosensitization, although the specific toxic effects on the liver and kidneys are not typical, it is recommended to take into account the accumulation of significant concentrations Impaired Glucose Tolerance in these organs and the possibility of accumulation of the drug. Pharmacotherapeutic group: L01CA01 - Antineoplastic agents. Side effects and complications in the use of drugs: more often - leukopenia, alopecia, rarely - hyperuricemia, mochekisly nephropathy, stomatitis, thrombocytopenia, muscle aches, nausea, vomiting, rarely - hemorrhagic colitis, or bleeding in the presence of ulcers, neyrointoksykatsiya (dizziness, head pain, diplopia, depression, paresthesia, Exotic Organism violation of the selection antydiuretychnoho hormone) from symptom onset neyrointoksykatsiyi stopping treatment. be dissolved by the solvent added (final district Leukocyte Adhesion Deficiency 0,1 mg / ml), this region can then be diluted 0,9% Mr Gastrointestinal Tract chloride and enter as in / to others.